Coronary Artery Bypass Grafting in a Patient with Myasthenia Gravis
AbstractA 70-year-old male patient with myasthenia gravis required coronary artery bypass grafting due to triple-vessel disease. The anesthetic management was performed with general anesthesia using reduced doses of muscle relaxants. He was extubated four hours after surgery and the postoperative course was uneventful. Coronary artery bypass surgery in myasthenic patients can be challenging to anesthesiologists and cardiac surgeons. In this rare condition, a meticulous assessment of the patient's neurologic and cardiac status, and careful perioperative anesthetic management were needed in order to avoid life-threatening complications in both intraoperative and postoperative periods.
Asai K, Suzuki K, Washiyama N, Terada H, Yahashita K, Kazui T. 2004. Combined operation for myasthenia gravis and coronary artery disease. J Thorac Cardiovasc Surg 52:65-7.nBaraka A, Haroun-Bizri S, Kawas N. 1999. Cisatracurium in the myasthenic patient. Can J Anesth 46:779-82.nBlichfeldt-Lauridsen L, Hansen BD. 2012. Anesthesia and myasthenia gravis. Acta Anaesthesiol Scand 56:17-22.nBuzello W, Noeldge G, Krieg N, Brobmann GF. 1986. Vecuronium for muscle relaxation in patients with myasthenia gravis. Anesthesiology 64:507-9.nHaroun-Bizri S, Maalouli J, Deeb P, Baraka A. 2003. Anesthetic management for a patient with myasthenia gravis undergoing coronary artery bypass graft. Middle East J Anesthesiol 17:299-305.nHayashida N, Kawara T, Akasu K, Kai E, Kosuga T, Chihara S, et al. 2000. Coronary artery bypass surgery in a patient with myasthenia gravis. Kurume Med J 47:173-5.nHunter JM, Bell CF, Florence AM, Jones RS, Utting JE. 1985. Vecuronium in the myasthenic patient. Anaesthesia 40:848-53.nIshimura H, Sata T, Matsumoto T, Takizura A, Shiqematsu A. 1998. Anesthetic management of a patient with myasthenia gravis during hypothermic cardiopulmonary bypass. J Clin Anesth 10:228-31.nLindstrom JM, Seybold ME, Lennon VA, Whittingham S, Duane DD. 1998. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology 51:933-9.nMcCarthy GJ, Mirakhur RK, Pandit SK. 1992. Lack of interaction between propofol and vecuronium. Anesth Analg 75:536-8.nNarin C, Sarkilar G, Tanyeli O, Ege E, Yeniterzi M. 2009. Successful mitral valve surgery in a patient with myasthenia gravis. J Card Surg 24:210-2.nOsserman KE, Genkis G. 1971. Studies in myasthenia gravis: review of twenty years experience in over 120 patients. MT Sinai J Med 38:497-537.nPaterson IG, Hood JR, Russel SH, Weston MD, Hirsch NP. 1994. Mivacurium in the myasthenic patient. Br J Anaesth 73:494-8.nPeacock JE, Cruickshank RH. 1989. Anaesthesia and rare diseases. Anesthesia. Nimmo WS, Smith G (eds). Blackwell Scientific Publications; 792-804.nRaimond F, Morel E, Bach JF. 1984. Evidence for the presence of immunoreactive acetylcholine receptors on human thymus cells. J Neuroimmunol 6:31-4.nRudzka-Nowak A, Piechota M. 2011. Anaesthetic management of a patient with myasthenia gravis for abdominal surgery using sugammadex. Arch Med Sci 7:361-4.nSanfilippo M, Fierro G, Cavalletti MV, Biancari F, Vilardi V. 1997. Rocuronium in two myasthenic patients undergoing thymectomy. Acta Anaesthesiol Scand 41:1365-6.nSungur Ulke Z, Senturk M. 2009. Mivacurium in patients with myasthenia gravis undergoing video-assisted thoracoscopic thymectomy. Br J Anesth 103:310-11.nUnterbuchner C, Fink H, Blobner M. 2010. The use of sugammadex in a patient with myasthenia gravis. Anaesthesia 65:302-5.nVincent A, Palace J, Hilton-Jones D. 2001. Myasthenia gravis. Lancet 357:2122-8.nYuan HK, Huang B-S, Kung S-Y, Kao KP. 2007. The effectiveness of thymectomy on seronegative generalized myasthenia gravis: comparing with seropositive cases. Acta Neurol Scand 115:181-4.n
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).